CliffBio
small molecule

DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)

DESMOPRESSIN ACETATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameDESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)
Active ingredientDESMOPRESSIN ACETATE
Strength0.01MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalJanuary 2005
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.